" class="no-js "lang="en-US"> CMO Archives - Medtech Alert
Thursday, March 28, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer

ImmVira, a biotechnology company focused on developing and synthesizing biological vector delivery platform, has announced […]

Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology

Invitae, a leading medical genetics company, has announced the appointment of Dr. W. Michael Korn, […]

Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer

Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for […]

Axogen Appoints Jens Schroeder Kemp as Chief Marketing Officer

Axogen, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, […]

Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer

Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first-in-class therapeutics for highly aggressive cancers, […]

Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer

Cardiff Oncology, a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more